InterVene, Inc. is excited to join a select group of medical device companies presenting innovative technologies at #TheVEINS24 Innovation Summit in Las Vegas this Sunday (11/3/2024). Kush Desai, MD will present InterVene's #Recana (formerly Chronus) system, currently in development for recanalizing chronic and postthrombotic (PT) venous occlusion and obstruction. Recana's design facilitates treatment in cases of chronic in-stent restenosis (ISR) and late percutaneous mechanical thrombectomy (PMT) for chronic tissue and obstructed and occluded venous stents. Dr. Desai takes the stage from 7:22-7:33 am during the Blue Sky Breakfast. Hope to see you there! #VIVA24 #chronicvenousinsufficiency #CVI #deepvenousstenting #deepveinthrombosis #DVT Jeff Elkins Catherine Matthes Jay Schmelter Andrew Kleiboeker
InterVene, Inc.
医疗设备制造业
Redwood City，California 1,360 位关注者
Developing interventional technologies to treat and prevent severe, complex venous diseases
关于我们
InterVene Inc. is a medical device company developing interventional technologies to treat and prevent chronic venous insufficiency (CVI) with a focus on deep veins and severe, complex venous diseases. The company’s Recana™ thrombectomy catheter system is designed to recanalize chronically obstructed deep veins and to facilitate treatment of in-stent restenosis, particularly in cases where recanalization options are limited or long-term stent maintenance is required. Recana is an investigational device limited by Federal (US) law to investigational use. Based in Redwood City, California, InterVene has assembled an exemplary team of employees, investors, advisors and board members, all possessing extensive vascular and venous interventional market experience.
- 网站
-
https://intervene-med.com/
InterVene, Inc.的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 11-50 人
- 总部
- Redwood City，California
- 类型
- 私人持股
- 创立
- 2012
地点
-
主要
获取路线
US，California，Redwood City，94063